KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $16.2 billion.

  • Quest Diagnostics' Liabilities and Shareholders Equity rose 63.37% to $16.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $64.1 billion, marking a year-over-year increase of 1063.64%. This contributed to the annual value of $16.2 billion for FY2024, which is 1519.75% up from last year.
  • Per Quest Diagnostics' latest filing, its Liabilities and Shareholders Equity stood at $16.2 billion for Q3 2025, which was up 63.37% from $16.0 billion recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Liabilities and Shareholders Equity registered a high of $16.2 billion during Q3 2025, and its lowest value of $12.8 billion during Q1 2023.
  • Its 5-year average for Liabilities and Shareholders Equity is $14.1 billion, with a median of $13.6 billion in 2021.
  • Per our database at Business Quant, Quest Diagnostics' Liabilities and Shareholders Equity plummeted by 568.66% in 2022 and then surged by 1938.14% in 2024.
  • Quest Diagnostics' Liabilities and Shareholders Equity (Quarter) stood at $13.6 billion in 2021, then dropped by 5.69% to $12.8 billion in 2022, then rose by 9.23% to $14.0 billion in 2023, then rose by 15.2% to $16.2 billion in 2024, then increased by 0.27% to $16.2 billion in 2025.
  • Its Liabilities and Shareholders Equity was $16.2 billion in Q3 2025, compared to $16.0 billion in Q2 2025 and $15.8 billion in Q1 2025.